Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study.

Autor: Rodrigues CO; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Spinardi J; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Rosa RG; Internal Medicine Department, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil. Electronic address: regisgoulartrosa@gmail.com., Falavigna M; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., de Souza EM; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Manfio JL; Research Institute, HMV, Porto Alegre, RS, Brazil., de Souza AP; Research Institute, HMV, Porto Alegre, RS, Brazil., de Araujo CLP; Research Institute, HMV, Porto Alegre, RS, Brazil., Cohen M; Research Institute, HMV, Porto Alegre, RS, Brazil; Federal University of Rio Grande do Sul (UFRGS), Brazil., Barbosa GRGDV; Research Institute, HMV, Porto Alegre, RS, Brazil., Silva FKR; Research Institute, HMV, Porto Alegre, RS, Brazil., Sganzerla D; Research Institute, HMV, Porto Alegre, RS, Brazil., da Silva MMD; Research Institute, HMV, Porto Alegre, RS, Brazil., Ferreira D; Otus Solutions, Porto Alegre, RS, Brazil., Kunkel NT; Research Institute, HMV, Porto Alegre, RS, Brazil., Camargo NI; Research Institute, HMV, Porto Alegre, RS, Brazil., Sarturi JC; Research Institute, HMV, Porto Alegre, RS, Brazil., Guilhem MC; Research Institute, HMV, Porto Alegre, RS, Brazil., de Oliveira JC; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Lopes CC; Research Institute, HMV, Porto Alegre, RS, Brazil., Widmar F; Research Institute, HMV, Porto Alegre, RS, Brazil., Barufi LK; Research Institute, HMV, Porto Alegre, RS, Brazil., da Silva GN; Research Institute, HMV, Porto Alegre, RS, Brazil., Gradia DF; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Brandalize APC; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Royer CA; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Luiz RM; Faculty of Medicine, Campus Toledo, Federal University of Paraná (UFPR), Brazil., Baura VA; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Abreu H; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Poitevin CG; Department of Biochemistry and Molecular Biology, Department of Genetics, UFPR, Brazil., Kucharski GA; Department of Health of Toledo, Toledo, PR, Brazil., Pedrotti F; Department of Health of Toledo, Toledo, PR, Brazil., Valluri SR; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Srivastava A; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA; Orbital Therapeutics, Cambridge MA, USA., Julião VW; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Melone OC; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Allen KE; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Kyaw MH; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., Castillo GDCM; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA., McLaughlin JM; Pfizer, Vaccines Medical and Scientific Affairs, Emerging Markets, Collegeville, PA, USA.

Publikováno v: Immunology letters [Immunol Lett] 2024 Oct; Vol. 269, pp. 106903. Date of Electronic Publication: 2024 Jul 26.